Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04123470
Title A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Lokon Pharma AB
Indications

melanoma

Therapies

Atezolizumab + LOAd703

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.